REQUEST A DEMO
Total
USD $0.00
Search more companies

Novartis Baltics SIA (Latvia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Novartis Baltics SIA Profile Updated: December 24, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Russian Download a sample report

Novartis Baltics SIA is a regional pharmaceutical company representing the Novartis group in the Baltic states. The companys business segments include marketing, distribution and regulatory support for prescription medicines across multiple therapeutic areas. Novartis Baltics SIA operates in Latvia, Lithuania and Estonia, coordinating commercial and medical activities in the region. Key assets include access to Novartis pharmaceutical portfolio, regulatory expertise and professional healthcare relationships. Strategically, the company focuses on improving patient access to innovative medicines, supporting healthcare systems and strengthening its regional presence in the pharmaceutical market.

Headquarters
Skanstes iela 25
Riga; Riga; Postal Code: 1013

Contact Details: Purchase the Novartis Baltics SIA report to view the information.

Website: https://www.novartis.com

Basic Information
Total Employees:
Purchase the Novartis Baltics SIA report to view the information.
Registered Capital:
Purchase the Novartis Baltics SIA report to view the information.
Financial Auditors:
Purchase the Novartis Baltics SIA report to view the information.
Incorporation Date:
May 24, 2017
Key Executives
Purchase this report to view the information.
Member of Management Board
Purchase this report to view the information.
Member of Management Board
Purchase this report to view the information.
Member of Management Board
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Novartis Baltics SIA report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
9.48%
Total operating revenue
9.2%
Operating profit (EBIT)
21.6%
EBITDA
21.6%
Net Profit (Loss) for the Period
N/A
Total Assets
12.58%
Total Equity
59.03%
Operating Profit Margin (ROS)
0.33%
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Quick Ratio
0.09%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?